Recursion Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.554; its P/E ratio is -6.54; Recursion Pharmaceuticals is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 10.53M	$ 11.02M	$ 12.13M	$ 13.68M	$ 13.05M
Gross Profit	$ -344.00K	$ 1.64M	$ -314.00K	$ 2.84M	$ -2.36M
EBIT	$ -92.99M	$ -81.63M	$ -69.86M	$ -60.98M	$ -60.43M
EBITDA	-	$ -76.09M	$ -66.14M	$ -57.77M	$ -57.44M
Net Income Common Stockholders	$ -93.02M	$ -76.73M	$ -65.33M	$ -57.49M	$ -60.45M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 387.32M	$ 409.19M	$ 474.46M	$ 551.19M	$ 454.65M
Total Assets	$ 630.83M	$ 666.70M	$ 627.37M	$ 701.29M	$ 611.53M
Total Debt	$ 51.48M	$ 52.90M	$ 53.05M	$ 51.01M	$ 52.19M
Net Debt	$ -335.85M	$ -356.30M	$ -421.40M	$ -500.19M	$ -402.46M
Total Liabilities	$ 192.86M	$ 197.74M	$ 197.19M	$ 215.48M	$ 223.50M
Stockholders Equity	$ 437.97M	$ 468.97M	$ 430.18M	$ 485.81M	$ 388.03M
Cash Flow	-
Free Cash Flow	-	$ -71.44M	$ -78.66M	$ -52.73M	$ -63.10M
Operating Cash Flow	$ -72.92M	$ -67.47M	$ -73.32M	$ -44.75M	$ -54.54M
Investing Cash Flow	$ -347.00K	$ -2.05M	$ -5.34M	$ -7.98M	$ 52.98M
Financing Cash Flow	$ 53.77M	$ 3.79M	$ 1.92M	$ 147.26M	$ 2.34M

Currency in USD

Recursion Pharmaceuticals Earnings and Revenue History

Income Statement >

Recursion Pharmaceuticals Debt to Assets

Balance Sheet >

Recursion Pharmaceuticals Cash Flow

Cash Flow >

Recursion Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing